- Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic
cardiomyopathy. Journal of the American College of Cardiology 2015;65(12):1249-54.
2. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on
diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and
Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European
heart journal 2014;35(39):2733-79.
3. Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hypertrophic cardiomyopathy: a review.
Anesth Analg. 2015;120(3):554-69.
4. Soler R, Méndez C, Rodríguez E, Barriales R, Ochoa JP, Monserrat L. Phenotypes of hypertrophic
cardiomyopathy. An illustrative review of MRI findings. Insights Imaging 2018;9(6):1007-20.
5. Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S. Prevalence of Hypertrophic
Cardiomyopathy in Highly Trained Athletes: Relevance to Pre-Participation Screening. Journal of the
American College of Cardiology 2008;51(10):1033-9.
6. Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. New England Journal of
Medicine. 2018;379(7):655-68.
7. Maron BJ, Rowin EJ, Maron MS. Global burden of hypertrophic cardiomyopathy. JACC: Heart Failure
2018;6(5):376-8.
8. Olivotto I, Cecchi F. The epidemiologic evolution and present perception of hypertrophic
cardiomyopathy. Italian Heart Journal 2003;4:596-601.
9. Syed IS, Ommen SR, Breen JF, Tajik AJ. Hypertrophic cardiomyopathy: identification of morphological
subtypes by echocardiography and cardiac magnetic resonance imaging. JACC: Cardiovascular Imaging
2008;1(3):377-9.
10. Antunes MdO, Scudeler TL. Hypertrophic cardiomyopathy. IJC Heart & Vasculatur 2020;27:100503.
11. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C. Compound and double mutations in
patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet
2005;42(10):e59-e.
12. Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, et al. Clinical features and outcome of
hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. Journal of the
American College of Cardiology 2010;55(14):1444-53.
- 13. Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, et al. Hypertrophic
cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PloS one
2017;12(11):e0187948.
14. Magnusson P, Palm A, Branden E, Mörner S. Misclassification of hypertrophic cardiomyopathy:
validation of diagnostic codes. Clinical Epidemiology 2017;9:403.
15. Kim EK, Lee S-C, Hwang JW, Chang S-A, Park S-J, On YK, et al. Differences in apical and non-apical
types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac
magnetic resonance findings and outcome from 350 patients. European Heart Journal–Cardiovascular
Imaging 2016;17(6):678-86.
16. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in
hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.
Heart 1997;77(2):130-2.
17. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American
College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic
cardiomyopathy: a report of the American College of Cardiology foundation task force on clinical expert
consensus documents and the European Society of Cardiology committee for practice guidelines. Journal of
the American College of Cardiology 2003;42(9):1687-713.
18. Helmy SM, Maauof GF, Shaaban AA, ElMaghraby AM, Anilkumar S, Shawky AHH, et al.
Hypertrophic cardiomyopathy: Prevalence, hypertrophy patterns, and their clinical and ECG findings in a
hospital at Qatar. Heart views: the official journal of the Gulf Heart Association 2011;12(4):143.
19. Turer AT, Samad Z, Valente AM, Parker MA, Hayes B, Kim RJ, et al. Anatomic and clinical correlates
of septal morphology in hypertrophic cardiomyopathy. European Journal of Echocardiography
2011;12(2):131-9.
20. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, et al. Hypertrophic cardiomyopathy
phenotype revisited after 50 years with cardiovascular magnetic resonance. Journal of the American College
of Cardiology 2009;54(3):220-8.
21. Romero-Farina G, Candell-Riera J, Pereztol-Valdés O, Galve-Basilio E, Palet-Balart J, del Castillo HG,
et al. Clasificación morfológica de la miocardiopatía hipertrófica mediante tomogammagrafía miocárdica.
Comparación con la clasificación ecocardiográfica. Revista Española de Cardiología 2000;53(4):511-6.
22. Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, et al. Echocardiographic diagnosis
of the different phenotypes of hypertrophic cardiomyopathy. Cardiovascular ultrasound 2015;14(1):1-12.
23. Kinoshita N, Nimura Y, Okamoto M, Miyatake K, Nagata S, Sakakibara H. Mitral regurgitation in
hypertrophic cardiomyopathy. Non-invasive study by two dimensional Doppler echocardiography. Heart
1983;49(6):574-83.
24. Hang D, Schaff HV, Nishimura RA, Lahr BD, Abel MD, Dearani JA, et al. Accuracy of jet direction on
Doppler echocardiography in identifying the etiology of mitral regurgitation in obstructive hypertrophic
cardiomyopathy. Journal of the American Society of Echocardiography 2019;32(3):333-40.
25. Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged Left Atrial Volume in
Hypertrophic Cardiomyopathy: A Marker for Disease Severity. Journal of the American Society of
Echocardiography 2005;18(10):1074-82.
|
